[Efficiency of immune correction in patients with chronic traumatic mandibular osteomyelitis].
The effect of a new immunomodulator neovir was studied in 35 patients with chronic traumatic mandibular osteomyelitis. The immune status and clinical parameters notably improved.
Zemskov
A M
AM
Korotkikh
N G
NG
Nektarevskaia
I B
IB
Suvorova
I M
IM
D000166:Acridines / Q000627:therapeutic use*; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D008297:Male; D008336:Mandibular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology*; D008338:Mandibular Injuries / Q000150:complications / Q000276:immunology; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology*; D016896:Treatment Outcome
D000166:Acridines; D000276:Adjuvants, Immunologic; C077681:Camedon